Unknown

Dataset Information

0

Pharmacotherapeutics of SARS-CoV-2 Infections.

ABSTRACT: The COVID-19 pandemic has affected more than 38 million people world-wide by person to person transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic and preventative strategies for SARS-CoV-2 remains a significant challenge. Within the past several months, effective treatment options have emerged and now include repurposed antivirals, corticosteroids and virus-specific antibodies. The latter has included convalescence plasma and monoclonal antibodies. Complete viral eradication will be achieved through an effective, safe and preventative vaccine. To now provide a comprehensive summary for each of the pharmacotherapeutics and preventative strategies being offered or soon to be developed for SARS-CoV-2.

SUBMITTER: Kevadiya BD 

PROVIDER: S-EPMC7785334 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The COVID-19 pandemic has affected more than 38 million people world-wide by person to person transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic and preventative strategies for SARS-CoV-2 remains a significant challenge. Within the past several months, effective treatment options have emerged and now include repurposed antivirals, corticosteroids and virus-specific antibodies. The latter has included convalescence plasma and monoclonal antibodies. Compl  ...[more]

Similar Datasets

Transcriptomics SM003 - icSARS CoV, SARS MA15 wild type and SARS BatSRBD mutant virus infections of C57BL6 mice - A time course
2014-02-15 | E-GEOD-50000 | biostudies-arrayexpress
Unknown Structures from "Engineering Neutralizing SARS-CoV Antibodies to Bind SARS-CoV-2"
| S-BSST379 | biostudies-other
Unknown SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development.
| S-EPMC7319644 | biostudies-literature
Unknown Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections.
| S-EPMC7239046 | biostudies-literature
Unknown Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.
| S-EPMC7231734 | biostudies-literature
Unknown The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
| S-EPMC7457039 | biostudies-literature
Unknown A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant
| S-SCDT-EMM-2021-15298 | biostudies-other
Genomics Tracking SARS-CoV-2 infections in Ghana
| PRJEB49489 | ENA
Unknown Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections.
| S-EPMC7372296 | biostudies-literature
Transcriptomics Stimulation of PSTPIP1 to trigger proinflammatory responses in asymptomatic SARS-CoV-2 infections
2023-07-11 | GSE236651 | GEO